QFLS:QSEQatar Fuel-Woqod QSC Analysis
Data as of 2026-05-24 - not real-time
QAR 14.15
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
QFLS is trading at roughly QAR 14.15, which sits well above its DCF‑derived fair value of about QAR 5.8, signaling a material pricing premium. The stock’s trailing PE of 14.4 is comfortably below the industry average of 21.6, suggesting relative earnings attractiveness. However, revenue has contracted by over 20% year‑over‑year and margins remain thin, limiting organic growth prospects. The company generates solid operating cash flow and maintains a modest debt‑to‑equity of roughly 13%, providing a stable balance sheet. A high dividend yield of 6.36% is attractive, though the payout ratio hovers near 92%, raising questions about long‑term sustainability. Overall, the fundamentals paint a classic “value” profile with income appeal but constrained growth.
On the technical side, the 20‑day SMA sits below the 50‑day and 200‑day SMAs, confirming a bearish price momentum. RSI at 40 indicates the stock is not yet oversold, while the MACD histogram has turned slightly positive, hinting at a tentative short‑term bounce. Volume trends are weakening, and price is flirting with the identified support around QAR 14.01, making downside risk palpable. Volatility over the past month is modest at about 9%, and the beta is effectively neutral, limiting market‑wide swings. The combination of the high dividend yield, limited upside, and bearish technical signals leads to an cautious stance. Investors should weigh the income benefit against the pricing premium and consider a hold in the near term, with a potential shift to a longer‑term buy if the dividend can be maintained.
On the technical side, the 20‑day SMA sits below the 50‑day and 200‑day SMAs, confirming a bearish price momentum. RSI at 40 indicates the stock is not yet oversold, while the MACD histogram has turned slightly positive, hinting at a tentative short‑term bounce. Volume trends are weakening, and price is flirting with the identified support around QAR 14.01, making downside risk palpable. Volatility over the past month is modest at about 9%, and the beta is effectively neutral, limiting market‑wide swings. The combination of the high dividend yield, limited upside, and bearish technical signals leads to an cautious stance. Investors should weigh the income benefit against the pricing premium and consider a hold in the near term, with a potential shift to a longer‑term buy if the dividend can be maintained.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish SMA alignment (20‑day below 50‑day and 200‑day)
- Decreasing volume trend
- Price near identified support level
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Valuation premium relative to DCF fair value
- Strong dividend yield with high payout ratio
- Modest operating cash flow and low debt
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Attractive dividend yield for income‑focused investors
- Stable balance sheet and low leverage
- Potential for earnings stabilization as market conditions normalize
Key Metrics & Analysis
Financial Health
Revenue Growth-21.30%
Profit Margin3.95%
P/E Ratio14.4
ROE11.64%
ROA2.74%
Debt/Equity12.63
P/B Ratio1.6
Op. Cash FlowQAR870.9M
Free Cash FlowQAR360.2M
Industry P/E21.6
Technical Analysis
TrendBearish
RSI40.4
SupportQAR 14.01
ResistanceQAR 14.54
MA 20QAR 14.23
MA 50QAR 14.43
MA 200QAR 14.93
MACDBullish
VolumeDecreasing
Fear & Greed Index91.61
Valuation
Fair ValueQAR 5.81
Target PriceQAR 15.36
Upside/Downside8.55%
GradeOvervalued
TypeValue
Dividend Yield6.36%
Risk Assessment
Beta-0.04
Volatility9.02%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.